NuVasive announces executive leadership changes

1179

NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, has announced executive leadership changes that will foster the company’s continued evolution into an increasingly profitable, US$1 billion start-up.

According to a press release issued by NuVasive recently, Quentin Blackford has been promoted to the Executive Leadership Committee as executive vice president of Finance and Investor Relations effective February 1, 2014. Blackford joined NuVasive in 2009, and with nearly 15 years of financial experience within medical device organisations, his effort and insight will be invaluable as NuVasive drives toward US$1 billion and beyond in revenues with improved profitability.

The company also announced the resignation of Craig Hunsaker, senior vice president of Global Human Resources, which will be effective March 31, 2014. Hunsaker will assist in the transition of his responsibilities to Mike Paolucci, who has been appointed executive vice president of Global Human Resources, effective immediately.

Mike Paolucci joins NuVasive from Life Technologies Corporation. He brings more than 20 years of broad global human resources experience at the executive and board level that will be instrumental to NuVasive’s evolution into a larger, global business, the press release reported. At Life Technologies, Paolucci was responsible for the global compensation and benefit programmes that encompassed more than 10,000 employees in nearly 40 countries. He also served as a human resources business partner for various business segments and was responsible for the company’s human resources technology systems.

Alex Lukianov, chairman and chief executive officer, said, “We are exceptionally grateful to Craig for all of his contributions during his tenure with NuVasive. I am thrilled to welcome both Quentin and Mike to the NuVasive Executive Committee. Their strong propensity for outstanding standards, steadfast focus, and wealth of experience in achieving excellent outcomes will be instrumental to our executive leadership team. I look forward to their contributions and have tremendous confidence in the team we have organised to help us achieve our market share taking strategy.”